RICHARDSON, Texas - October 9, 2018 - (Newswire.com)
One Stem Cell Lab, continues to follow FDA regulations of minimally manipulated tissue and explicitly does NOT manufacture, distribute, the use of cord blood (Hematic Stem Cells-HSC) in any of One Stem Cell Lab’s Products. One Stem Cell Lab is regulated solely under the authority of section 361 of the PHS Act and the regulations in 21 CFR Part 1271.
In light of recent events, One Stem Cell Lab, a pioneer in the industry, explicitly follows FDA Regulations for minimally manipulated tissue. Our intravenous and sub-cutaneous injections do not contain any cord blood and are strictly mesenchymal stem cells (MSC).
For further inquiries please contact One Stem Cell Lab at:
1(833)-267-3522
www.onestemcelllab.com
Related Links
FDA
Related Files
FDADraftGuildance2017.pdf
Press Release Service by Newswire.com
Original Source: One Stem Cell Lab, Continues to Follow FDA Regulations of Minimally Manipulated Tissue and Explicitly Does NOT Manufacture, Distribute, the Use of Cord Blood (Hematic Stem Cells-HSC) in Any of One Stem Cell Lab's Products.
